LivaNova (NASDAQ:LIVN) Sets New 12-Month High – What’s Next?

Shares of LivaNova PLC (NASDAQ:LIVN) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $65.95 and last traded at $64.6850, with a volume of 38349 shares traded. The stock had previously closed at $64.71.

Analysts Set New Price Targets

A number of analysts have recently commented on LIVN shares. Weiss Ratings restated a “sell (d+)” rating on shares of LivaNova in a research report on Monday, December 29th. Robert W. Baird set a $75.00 price target on shares of LivaNova in a research note on Tuesday, December 16th. Barclays upped their price objective on shares of LivaNova from $58.00 to $67.00 and gave the stock an “equal weight” rating in a research report on Friday, January 9th. Wall Street Zen upgraded shares of LivaNova from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 20th. Finally, The Goldman Sachs Group reissued a “neutral” rating and set a $66.00 target price on shares of LivaNova in a research note on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $69.38.

LivaNova Price Performance

The stock has a market cap of $3.59 billion, a PE ratio of -16.43 and a beta of 0.97. The stock’s fifty day moving average is $63.09 and its 200-day moving average is $55.92. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.33 and a quick ratio of 1.12.

Institutional Investors Weigh In On LivaNova

Several large investors have recently bought and sold shares of the stock. GAMMA Investing LLC increased its holdings in shares of LivaNova by 182.5% in the 2nd quarter. GAMMA Investing LLC now owns 630 shares of the company’s stock valued at $28,000 after acquiring an additional 407 shares during the last quarter. State of Wyoming acquired a new position in LivaNova in the second quarter valued at approximately $31,000. Quarry LP purchased a new position in LivaNova in the third quarter valued at approximately $36,000. EverSource Wealth Advisors LLC raised its holdings in LivaNova by 998.4% during the second quarter. EverSource Wealth Advisors LLC now owns 703 shares of the company’s stock worth $32,000 after purchasing an additional 639 shares in the last quarter. Finally, UMB Bank n.a. raised its holdings in LivaNova by 63.0% during the third quarter. UMB Bank n.a. now owns 792 shares of the company’s stock worth $41,000 after purchasing an additional 306 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.